Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges

The Quick Take
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Economic Times.
Related
Business
93 Greenberg Traurig Attorneys Included on 2026 New York Metro Super Lawyers Lists
NEW YORK, Oct. 30, 2026 /PRNewswire/ -- Ninety-three attorneys from global law firm Greenberg Traurig, LLP are included on the 2026 New York Metro Super…
Business
Solid State Relay Market worth $2.68 billion by 2032 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 30, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Solid State Relay Market is projected to reach USD 1.85 billion in 2026…
Business
New England Honda Group Continues Support of the Jimmy Fund Through Boston Marathon Partnership
DANVERS, Mass., Oct. 30, 2026 /PRNewswire/ -- During the 130th running of the Boston Marathon presented by Bank of America, the New England Honda Group…
Business
Graphene Market Set to Reach US$ 3.94 Billion by 2031 as Demand for Next-Generation Materials Accelerates
SHERIDAN, Wyo., Oct. 30, 2026 /PRNewswire/ -- The global graphene market is valued at USD 970 million in 2026 and is projected to reach USD 3.94 billion by…
